Skip to main content
Monday, November 16, 2026Nov 16

Can costs of big-ticket health care treatments be contained?

Money tile
Money tile

Are there ways to control America’s rocketing cost of health care?

The higher costs for specialty drugs are not always bad for insurers. Though initial costs may be high for chronic diseases such as hepatitis C or multiple sclerosis, the long-term costs without the drug may be even higher.

Even if the long-term cost is not higher, insurance companies are required to pay for a new drug once it is proved to be effective.

“A lot of them don’t have another alternative,” said Sherri Zink, senior vice president and chief data officer for BlueCross BlueShield.

But if drug costs keep going higher and higher, insurers will be forced to keep raising rates or find some way to limit access to the drugs.